DNA X Inc (SONM) FinancialsSONMDNA X Inc

DNA X Inc (SONM) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Smartphones, accounting for 50.0% of total sales, equivalent to $8.11M. Other significant revenue streams include Connected solutions and Feature Phones. Understanding this composition is critical for investors evaluating how SONM navigates market cycles within the Phones & Handheld Devices industry.

In the context of the broader market, SONM competes directly with industry leaders such as IVDA and UTSI. With a market capitalization of $5.42M, it holds a significant position in the sector. When comparing efficiency, SONM's gross margin of N/A stands against IVDA's 54.69% and UTSI's -13.59%. Such benchmarking helps identify whether DNA X Inc is trading at a premium or discount relative to its financial performance.

Sonim Technologies has reported zero revenue in several quarters, with a net income loss of $12.47 million in the last quarter. The gross margin is only 11.20%, which is low for a company in its sector. The current ratio is also concerning at 0.76, indicating potential liquidity issues.